Write For Us

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech

Sponsored Post Vitamin D2 Canada Persia
96 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Covid Vaccine: Phase 3 results for Bharat Biotech's coronavirus vaccine - Covaxin - were released Wednesday afternoon, with the drug demonstrating "81 per cent interim efficacy in preventing COVID-19 in those without prior infection after the second dose", according to a statement by the company.NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
Category
Asia
Tags
NDTV 24x7, Efficacy, Covaxin Efficacy
Sign in or sign up to post comments.
Be the first to comment